Cargando…

An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment

While checkpoint blockade immunotherapies have widespread success, they rely on a responsive immune infiltrate; as such, treatments enhancing immune infiltration and preventing immunosuppression are of critical need. We previously generated αPD-1 resistant variants of the murine HNSCC model MEER. Wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	DePeaux, Kristin, Rivadeneira, Dayana B., Lontos, Konstantinos, Dean, Victoria G., Gunn, William G., Watson, McLane J., Yao, Tianhong, Wilfahrt, Drew, Hinck, Cynthia, Wieteska, Lukasz, Thorne, Stephen H., Hinck, Andrew P., Delgoffe, Greg M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407786/ https://www.ncbi.nlm.nih.gov/pubmed/37552475 http://dx.doi.org/10.1084/jem.20230053

Ejemplares similares

Biological Activity Differences between TGF-β1 and TGF-β3 Correlate with Differences in the Rigidity and Arrangement of Their Component Monomers
por: Huang, Tao, et al.
Publicado: (2014)

Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
por: Scharping, Nicole E., et al.
Publicado: (2021)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Convergent evolution of a parasite-encoded complement control protein-scaffold to mimic binding of mammalian TGF-β to its receptors, TβRI and TβRII
por: Mukundan, Ananya, et al.
Publicado: (2022)

P03.03. Facebook use and professionalism among CAM students
por: Hinck, G, et al.
Publicado: (2012)

Metabolic support of tumor-infiltrating regulatory T cells by lactic acid
por: Watson, McLane J., et al.
Publicado: (2021)

4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
por: Menk, Ashley V., et al.
Publicado: (2018)

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
por: Lontos, Konstantinos, et al.
Publicado: (2022)

Fighting in a wasteland: deleterious metabolites and antitumor immunity
por: Watson, McLane J., et al.
Publicado: (2022)

Key stages in mammary gland development: The mammary end bud as a motile organ
por: Hinck, Lindsay, et al.
Publicado: (2005)

Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: evidence to date
por: Zavras, PD, et al.
Publicado: (2019)

The Amino Acid Specificity for Activation of Phenylalanine Hydroxylase Matches the Specificity for Stabilization of Regulatory Domain Dimers
por: Zhang, Shengnan, et al.
Publicado: (2015)

Current practice of antibiotic utilization for renal colic in the emergency room
por: Hinck, Bryan, et al.
Publicado: (2017)

Late diagnosis of Barth syndrome in a 39‐year‐old patient with non‐compaction cardiomyopathy and neutropenia
por: Seitz, Andreas, et al.
Publicado: (2020)

Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors
por: Lontos, Konstantinos, et al.
Publicado: (2023)

A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands
por: Qin, Tai, et al.
Publicado: (2016)

Correction: A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands
por: Qin, Tai, et al.
Publicado: (2017)

CD44 acts as a coreceptor for cell-specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimic
por: van Dinther, Maarten, et al.
Publicado: (2023)

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010)

Overcoming the limitations of locally administered oncolytic virotherapy
por: Hong, JinWoo, et al.
Publicado: (2019)

TGFβ(+) small extracellular vesicles from head and neck squamous cell carcinoma cells reprogram macrophages towards a pro‐angiogenic phenotype
por: Ludwig, Nils, et al.
Publicado: (2022)

TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition
por: Ramachandran, Anassuya, et al.
Publicado: (2018)

Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
por: Moertel, Christopher, et al.
Publicado: (2013)

The Coach–Athlete Relationship in Strength and Conditioning: High Performance Athletes’ Perceptions
por: Foulds, Steven J., et al.
Publicado: (2019)

89723 CD105-targeted CAR T cells for the treatment of acute myeloid leukemia
por: Lontos, Konstantinos, et al.
Publicado: (2021)

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
por: Liu, Junfeng, et al.
Publicado: (2023)

A structurally distinct TGF-β mimic from an intestinal helminth parasite potently induces regulatory T cells
por: Johnston, Chris J. C., et al.
Publicado: (2017)

Activation of Phenylalanine Hydroxylase by Phenylalanine Does Not Require Binding in the Active Site
por: Roberts, Kenneth M., et al.
Publicado: (2014)

Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model
por: Oh, Eonju, et al.
Publicado: (2016)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014)

Skills, Satisfaction, and Future Recommendations for Salary and Benefit Negotiation Success Among Nutrition and Dietetics Professionals in the United States
por: McKinley, Erin, et al.
Publicado: (2022)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
por: Marchini, Antonio, et al.
Publicado: (2016)

PKR induces TGF-β and limits oncolytic immune therapy
por: Hong, Bangxing, et al.
Publicado: (2023)

Theranostic Potential of Oncolytic Vaccinia Virus
por: Rojas, Juan J, et al.
Publicado: (2012)

Acute and endothelial-specific Robo4 deletion affect hematopoietic stem cell trafficking independent of VCAM1
por: Smith-Berdan, Stephanie, et al.
Publicado: (2021)

Oncolytic viruses: finally delivering
por: Seymour, Leonard W, et al.
Publicado: (2016)

Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
por: Zhang, Yalei, et al.
Publicado: (2021)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rf2hmbquko9sn6ngea365nsrt9